deltatrials

Overactive bladder Trials in Warsaw, Poland

Conditions / Overactive bladder / Warsaw, Poland

Overactive bladder is a medical condition with active clinical research programs worldwide.

18 total trials for this combination

Showing top 10 of 18 trials

Trials

NCT ID Title Status Phase
NCT02045862 A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder COMPLETED PHASE3
NCT02660138 Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 TERMINATED PHASE3
NCT01093534 Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. COMPLETED PHASE4
NCT00337090 A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON) COMPLETED PHASE2
NCT02757768 A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) COMPLETED PHASE4
NCT00478881 A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function COMPLETED PHASE2
NCT00168454 A Research Study for Patients With Overactive Bladder COMPLETED PHASE2
NCT00444925 Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB) COMPLETED PHASE3
NCT00337558 A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) COMPLETED PHASE4
NCT01972841 This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder COMPLETED PHASE3

Related Pages